Abstract:Highlights • The core composition of the tablet included an extended-release polymer (Kollidon SR) and permeability enhancer (Vitamin E TPGS) with the drug (Mesalamine) to extend the drug release and enhance drug absorption. • Shell composition contains dual polymer; Eudragit L-100 for pH-sensitive release in the colon at pH above 6 and HPMC HME L-100 for gel formation to prevent release in the upper GI tract. • Shell filament produced via hot-melt extrusion (HME) and 3D printed to ensure protection of the core tablet. Objectives The present study is intended to develop a shell-core tablet using a hot melt extrusion (HME)-based dual-nozzle fused deposition modeling (FDM) three-dimensional (3D) printing approach. The primary objective was to establish a sustained-release colonic drug delivery system and improve mesalamine's permeability by incorporating Vitamin E TPGS as a permeation enhancer. Method The study utilized Kollidon® SR for sustained release, L-100, and HPMC HME L100 for the tablet's protective shell. Six filament formulations were tested, and the mechanical properties of the shell filaments, including the three-point bending, Hooke's law, and stiffness, were assessed. Drug release profiles of the tablets were evaluated using the USP-II dissolution apparatus, and permeability characteristics were gauged using the non-everted intestinal sac method. Solutions containing 5% w/v mesalamine and 2.5% w/v Vitamin E TPGS were employed, with pure mesalamine as a control. Results Optimal filament ratios were identified as 50:50 for the core and 30:70 for Eudragit L-100 to HPMC HME L100 for the shell. The resulting tablets achieved a prolonged drug release of up to 24 hours for the core. They ensured minimal drug release in the upper gastrointestinal tract (∼5% in the first 5 hours), effectively targeting the colon. Incorporating Vitamin E TPGS led to a 3.6-fold increase in mesalamine absorption compared to the control, and the addition of Kollidon® SR notably improved the flow properties of Mesalamine powder. Conclusion In conclusion, this innovative approach has the potential to achieve a colon-specific drug delivery system. Graphical abstract Download : Download high-res image (176KB) Download : Download full-size image

A core-shell multi-drug platform to improve gastrointestinal tract microbial health using 3D printing

Three-Dimensional Electrohydrodynamic Printing and Spinning of Flexible Composite Structures for Oral Multidrug Forms

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Fabrication of Flexible Composite Drug Films Via Foldable Linkages Using Electrohydrodynamic Printing

3D printed spiral tube-like cellulose scaffold for oral delivery of probiotics

Microencapsulation of Bifidobacterium lactis and Lactobacillus plantarum within a Novel Polysaccharide-Based Core-Shell Formulation: Improving Probiotic Viability and Mucoadhesion

Design of 3D printed insert for hanging culture of Caco-2 cells.

Colonic Delivery of Aqueous Suspensions Using 3D Printed Capsules

Microfluidic-based Multifunctional Microspheres for Enhanced Oral Co-Delivery of Probiotics and Postbiotics

Bioinspired core-shell microparticle for dual-delivery of prebiotic and probiotic for the treatment of ulcerative colitis

Combining Coaxial Electrospinning and 3D Printing: Design of Biodegradable Bilayered Membranes with Dual Drug Delivery Capability for Periodontitis Treatment

Multishell Colloidosome Platform with Sequential Gastrointestinal Resistance for On-Demand Probiotic Delivery.

Structure-Based Gastro-Retentive and Controlled-Release Drug Delivery with Novel 3D Printing

Construction of Probiotic Double-Layered Multinucleated Microcapsules Based on Sulfhydryl-Modified Carboxymethyl Cellulose Sodium for Increased Intestinal Adhesion of Probiotics and Therapy for Intestinal Inflammation Induced by Escherichia coli O157:H7

Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells

Colon-targeted 3D-Printed mesalamine tablets: Core-shell design and in vitro/ex-vivo evaluation

Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy

3D Printed pH-responsive Colonic Capsules for the Delivery of Live Aqueous Bacterial Suspensions

Feasibility study into the potential use of fused-deposition modeling to manufacture 3D-printed enteric capsules in compounding pharmacies

Core-shell nanofibers based on microalgae proteins/alginate complexes for enhancing survivability of probiotics